Wei‐Ming Li
Impact in
- Urology top 1%
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Surgery 68
- Bladder and Urothelial Cancer Treatments 43
- Urinary and Genital Oncology Studies 15
-
- Circular RNAs in diseases 9
- Epigenetics and DNA Methylation 9
- Co-authors
- Wen‐Jeng Wu (102 shared papers)Hung‐Lung Ke (63 shared papers)Hsin‐Chih Yeh (48 shared papers)Chun‐Nung Huang (40 shared papers)Ching‐Chia Li (29 shared papers)Chien‐Feng Li (35 shared papers)Yawei Xu (13 shared papers)San‐Yuan Chen (7 shared papers)
- Journals
- Frontiers in Oncology (7 papers)Oncotarget (7 papers)PLoS ONE (5 papers)Cancers (5 papers)The Journal of Urology (5 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Wei‐Ming Li
255 papers receiving 4.9k citations
Wei‐Ming Li's Hit Papers
Peers
Comparison fields: 5 of 156
- Urology 291
- Cancer Research 539
- Surgery 901
- Nephrology 148
- Endocrinology, Diabetes and Metabolism 308
Countries citing papers authored by Wei‐Ming Li
This map shows the geographic impact of Wei‐Ming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Ming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Ming Li more than expected).
Fields of papers citing papers by Wei‐Ming Li
This network shows the impact of papers produced by Wei‐Ming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Ming Li. The network helps show where Wei‐Ming Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐Ming Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 269 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | High Doses of Bone Morphogenetic Protein 2 Induce Structurally Abnormal Bone and Inflammation In Vivo Hit paper breakdown → | 2011 | 487 |
| 2 | 2016 | 125 | |
| 3 | 1999 | 124 | |
| 4 | 2010 | 124 | |
| 5 | Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention. | 2007 | 108 |
| 6 | 2005 | 91 | |
| 7 | 2014 | 87 | |
| 8 | 2008 | 86 | |
| 9 | 2012 | 71 | |
| 10 | 2009 | 69 | |
| 11 | 2020 | 64 | |
| 12 | 2007 | 61 | |
| 13 | 2020 | 58 | |
| 14 | 2014 | 58 | |
| 15 | 2012 | 57 | |
| 16 | 2015 | 56 | |
| 17 | 2011 | 55 | |
| 18 | 2003 | 54 | |
| 19 | 2018 | 54 | |
| 20 | 2010 | 53 |
About Wei‐Ming Li
Wei‐Ming Li is a scholar working on Surgery, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 269 papers that have together received 5.0k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (43 papers), Urinary and Genital Oncology Studies (15 papers), Ferroptosis and cancer prognosis (13 papers), Chronic Myeloid Leukemia Treatments (12 papers), Kidney Stones and Urolithiasis Treatments (11 papers), Cancer-related molecular mechanisms research (10 papers), Circular RNAs in diseases (9 papers) and Epigenetics and DNA Methylation (9 papers). The work is most often cited by research in Urology (291 citations), Cancer Research (539 citations), Surgery (901 citations), Nephrology (148 citations) and Endocrinology, Diabetes and Metabolism (308 citations). Wei‐Ming Li has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Wen‐Jeng Wu, Hung‐Lung Ke, Hsin‐Chih Yeh, Chun‐Nung Huang, Ching‐Chia Li, Chien‐Feng Li, Yawei Xu, San‐Yuan Chen, Ching‐Chia Li and Xinli Zhang. Their work appears in journals such as Frontiers in Oncology, Oncotarget, PLoS ONE, Cancers and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.